Molecular Characteristics of Gastroesophageal Adenocarcinoma (MOCHA): A Prospective Feasibility Study
NCT04219137 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 120
Last updated 2025-05-14
Summary
Researchers are looking to further our knowledge on disease biology and treatment selection for gastroesophageal adenocarcinoma. The purpose of this study is to see how useful it is to look for changes and characteristics in your genes (molecules that contain instructions for the development and functioning of the cells) and the genes within the tumour. These characteristics may be useful in choosing treatments for patients for the future.
Conditions
- Esophagogastric Adenocarcinoma
Interventions
- GENETIC
-
Molecular Profiling
This is a correlative study collecting biosamples to evaluate genomic characteristics and treatment outcomes of gastroesophageal adenocarcinoma.
Sponsors & Collaborators
-
University Health Network, Toronto
lead OTHER
Principal Investigators
-
Elena Elimova · University Health Network, Toronto
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-11-14
- Primary Completion
- 2027-11-30
- Completion
- 2027-11-30
Countries
- Canada
Study Locations
More Related Trials
-
Liquid Biopsy in Monitoring the Neoadjuvant Chemotherapy and Operation in Gastric Cancer
NCT03957564 ·Status: UNKNOWN ·Phase: PHASE2
-
InteGRAtive Analysis of TuMor, Microenvironment, ImmunitY and Patient Expectation for Personalized Response Prediction in Gastric Cancer
NCT04842916 ·Status: RECRUITING
-
A Study to Evaluate Sacituzumab Tirumotecan (MK-2870) in Advanced/Metastatic Gastroesophageal Adenocarcinoma (MK-2870-015)
NCT06356311 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Genomic Evolution of Metastasis in Gastric Cancer
NCT05061082 ·Status: UNKNOWN
-
The Efficacy of Precision Treatment for Gastric Cancer Guided by Molecular Profiling
NCT04501887 ·Status: UNKNOWN
-
Pharmacogenomically Selected Treatment for Gastric and Gastroesophageal Junction (GEJ) Tumors
NCT00515216 ·Status: COMPLETED ·Phase: PHASE2
-
BGB A317 in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Carcinoma
NCT03469557 ·Status: COMPLETED ·Phase: PHASE2
-
BReast CAncer Genes(BRCA) Expressions in Metastatic Gastric Cancer
NCT03838406 ·Status: COMPLETED ·Phase: NA
-
Predicting Biomarker of Gastric Cancer Chemotherapy Response
NCT03253107 ·Status: RECRUITING
-
Mecapegfilgrastim Combined With Adebrelimab and Chemotherapy as Neoadjuvant Therapy in Resectable GC/GEJC
NCT06684158 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Chemoprevention of Gastric Carcinogenesis
NCT02794428 ·Status: COMPLETED ·Phase: PHASE2
-
Prognostic and Predictive Impact of Circulating Tumor DNA in Gastric Cancer Treatment
NCT02674373 ·Status: UNKNOWN
-
Bortezomib in Treating Patients With Unresectable or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
NCT00074009 ·Status: COMPLETED ·Phase: PHASE2
-
Gastric Cancer Registry for Epidemiology and Molecular Risk Factor
NCT03046745 ·Status: UNKNOWN
-
Prospective Evaluation and Molecular Profiling in People With Gastric Tumors
NCT03027427 ·Status: COMPLETED
-
Pharmacogenomic Study (Adjuvant Chemotherapy)
NCT01470404 ·Status: COMPLETED
-
Integrative Analysis of Exosome-Mediated Single-Cell Transcriptomics and Proteomics in Gastric Cardia Cancer
NCT06702891 ·Status: RECRUITING
-
Doxorubicin, Cisplatin, 5-Fluorouracil in Patients With Advanced Adenocarcinoma of the Stomach or Esophagus
NCT00165191 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma
NCT00515411 ·Status: COMPLETED ·Phase: PHASE2
-
mDCF + Avelumab in Resectable Esophago-gastric Adenocarcinoma (EGA)
NCT03288350 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy and Safety of Neoadjuvant Chemoradiation Plus Serplulimab in Patients With Locally Advanced Adenocarcinoma of Gastroesophageal Junction
NCT05918419 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy of Irinotecan and Capecitabine Versus(vs) Cisplatin and Capecitabine in Patients With Esophago-Gastric Cancer
NCT00675194 ·Status: COMPLETED ·Phase: PHASE2
-
Optimizing the Strategy for Preoperative Chemotherapy in Locally Advanced Gastric/Gastroesophageal Cancer
NCT02725424 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 2 Study to Evaluate the Safety and Efficacy of Max-40279-01 in Patients With Advanced Gastric Cancer or Gastroesophageal Junction Cancer
NCT05395780 ·Status: UNKNOWN ·Phase: PHASE2
-
Treatment of Advanced Gastrointestinal Cancer in a Phase I/II Trial With Modified Autologous MSC_apceth_101
NCT02008539 ·Status: TERMINATED ·Phase: PHASE1/PHASE2